Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Medical Facilities Corporation (31F.F)

9.20
+0.10
+(1.10%)
As of 8:02:00 AM GMT+2. Market Open.
Loading Chart for 31F.F
  • Previous Close 9.10
  • Open 9.20
  • Bid 9.15 x --
  • Ask 9.75 x --
  • Day's Range 9.20 - 9.20
  • 52 Week Range 7.20 - 11.80
  • Volume 250
  • Avg. Volume 75
  • Market Cap (intraday) 187.192M
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 7.67
  • EPS (TTM) 1.20
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.23 (2.51%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est --

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States. Its specialty surgical hospitals offer non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as urgent care and occupational health; and ambulatory surgery center provides scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.

www.medicalfacilitiescorp.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 31F.F

View More

Performance Overview: 31F.F

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

31F.F
8.17%
S&P/TSX Composite index (^GSPTSE)
0.60%

1-Year Return

31F.F
26.63%
S&P/TSX Composite index (^GSPTSE)
11.88%

3-Year Return

31F.F
41.34%
S&P/TSX Composite index (^GSPTSE)
15.51%

5-Year Return

31F.F
364.89%
S&P/TSX Composite index (^GSPTSE)
69.71%

Compare To: 31F.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 31F.F

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    185.16M

  • Enterprise Value

    154.71M

  • Trailing P/E

    7.59

  • Forward P/E

    10.41

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.75

  • Price/Book (mrq)

    1.65

  • Enterprise Value/Revenue

    0.53

  • Enterprise Value/EBITDA

    2.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.17%

  • Return on Assets (ttm)

    9.26%

  • Return on Equity (ttm)

    42.74%

  • Revenue (ttm)

    331.53M

  • Net Income Avi to Common (ttm)

    24.72M

  • Diluted EPS (ttm)

    1.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.5M

  • Total Debt/Equity (mrq)

    50.14%

  • Levered Free Cash Flow (ttm)

    72.09M

Research Analysis: 31F.F

View More

Company Insights: 31F.F

Research Reports: 31F.F

View More